-
Featured Authors
Patently BIOtech
Archive
- May 2013 (2)
- April 2013 (5)
- March 2013 (2)
- February 2013 (4)
- January 2013 (1)
- December 2012 (2)
- November 2012 (3)
- October 2012 (3)
- September 2012 (3)
- August 2012 (5)
- July 2012 (4)
- June 2012 (7)
- May 2012 (5)
- April 2012 (3)
- March 2012 (4)
- February 2012 (6)
- January 2012 (2)
- December 2011 (2)
- November 2011 (3)
- October 2011 (3)
- September 2011 (5)
- August 2011 (4)
- July 2011 (8)
- June 2011 (16)
- May 2011 (8)
- April 2011 (9)
- March 2011 (14)
- February 2011 (9)
- January 2011 (15)
- December 2010 (7)
- November 2010 (6)
- October 2010 (4)
- June 2010 (1)
- May 2010 (4)
- April 2010 (14)
- March 2010 (4)
- January 2010 (5)
- November 2009 (3)
- October 2009 (1)
- August 2009 (6)
- July 2009 (9)
- June 2009 (9)
- May 2009 (8)
- April 2009 (9)
- March 2009 (9)
- February 2009 (3)
- January 2009 (1)
- November 2008 (1)
Category Archives: Patently BIOtech
Bloggers Cover IP at the 2009 International Convention
Both Patent Baristas and Patent Docs wrote up some great analyses of the ip sessions at the 2009 BIO International Convention. Visit www.patentbaristas.com and www.patentdocs.net to view their posts on patent reform, biosimilars, healthcare reform, USPTO reform efforts, and more.
For U.S. Healthcare Reform and Global Health Crises, Both Public and Private Efforts Needed
How can we address health needs in both the United States and developing countries at the same time? By bringing everyone to the table for open, fair, collaborative partnerships. It saves money, time, effort and – most important of all – lives.
IP Think Tank Podcast: Biotech Intellectual Property at the Crossroads
Thanks to the IP Think Tank blog, we have a great podcast on Biotech Now where Gregory Glover, a panellist at the 2009 BIO International Convention about the pending Biosimilar legislation and concerns over situations where a follow on product might avoid patent claims but still be able to rely on innovator regulatory data.
China IP Forum to Bring Third Patent Amendment Face-to-Face with Biotechnology Concerns
Emerging markets, particularly the China market, have become a strategic area for pharmaceutical and chemical companies and law firms. China’s lawmakers adopted third revision of the law recently, which will bring a number of substantial changes to the Chinese patent system.
BIO 2009: How Biotech Helps Heal, Fuel, and Feed the World
I’ll be writing updated about the top IP events at the 2009 BIO International Convention (convention.bio.org).
